FY18 results conference call
Zealand will host a conference call on March 7, 2019 at 4 PM CET (10 AM EST)
Applying our peptide platform to specialty disease areas to invent novel therapies.
Advancing fully owned development programs with Phase 3 in two rare disease programs. See our pipeline